Ligand Pharmaceuticals
LGND
#4132
Rank
A$3.38 B
Marketcap
$178.99
Share price
4.47%
Change (1 day)
100.90%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.36

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.41. In 2022 the company made an earnings per share (EPS) of -$3.04 a decrease over its 2021 EPS that were of $5.31.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.36-177.66%
2022-$3.04-157.23%
2021$5.31-2571.43%
2020-$0.21-100.46%
2019$47.01353.48%
2018$10.371025%
2017$0.92-700%
2016-$0.15-100.87%
2015$17.751859.32%
2014$0.915.36%
2013$0.868.0704505322479E+18%
2012$0.0000000000-100%
2011$0.75-194.23%
2010-$0.80548.38%
2009-$0.12-98.7%
2008-$9.49-136.52%
2007$25.98-787.8%
2006-$3.78-14.58%
2005-$4.42-21.31%
2004-$5.62-55.15%
2003-$12.5381.33%
2002-$6.912.74%
2001-$6.73-45.93%
2000-$12.44-14.56%
1999-$14.56-45.52%
1998-$26.72-3.97%
1997-$27.83132.31%
1996-$11.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$21.73 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.55-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.38 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.80 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.86 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.34 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.10 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.86 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.63 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA